...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Toxicity

I could be wrong but I don't see the two we're speaking about on slide 5 in the last presentation. ???

http://118009.choruscall.com/zenithepigenetics/zenith20221027.pdf

Koo

Share
New Message
Please login to post a reply